home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Mendel Biotechnology's trait technology advances towards commercial launch


Hayward, California, USA
September 28, 2011

Mendel Biotechnology Inc. ("Mendel") announced today that a regulatory petition by Monsanto Company was made recently to the USDA for soybean plants containing Mendel's leading yield gene. The filing is a key part of the regulatory path as the trait moves closer to commercial launch. Approval of the petition is one of the final milestones needed to make the high yield soybean plants available to farmers.

The underlying yield gene represents Mendel's flagship commercial trait technology and was discovered and developed through a research collaboration funded by Monsanto leveraging Mendel's deep expertise in plant gene regulation and network biology. Mendel possesses patent rights related to this yield gene in major agricultural production geographies and sees application potential for the gene to be licensed in various fields, including forestry, energy crops and others. Mendel, which has remained privately held since it was founded in 1997, has developed a leading portfolio of ag biotech traits for improved yield and stress tolerance in large acreage and high value crops. In addition to already having a number of trait technologies that were developed in the past decade, Mendel is deploying a suite of state-of-the-art, genomics-based technical platforms for discovery and development of new technologies to meet global yield and stress tolerance targets and the need for improved efficiency of using resources like water and nitrogen.

As well as working to commercialize its current traits, Mendel is also deploying its knowledge of plant gene regulatory networks to the discovery of novel chemistries to improve plant performance in its Chemistry business segment, and to the development of improved varieties of the premier energy crop, miscanthus, in its seeds business segment.

"We are absolutely delighted that Monsanto has submitted a dossier for deregulation of soybean plants that contain our high-yield gene. This submission underscores our belief in the potential of our technology strategy and business and validates our long term R&D strategy focused on understanding and improving the regulation of gene networks that control important plant traits," said Neal Gutterson, President and Chief Executive Officer of Mendel. "With the continued development of this and other technologies, we are now in position to apply our knowledge of gene networks and our technology platforms to the discovery and development of additional biotech traits."



More news from: Mendel Biotechnology


Website: http://www.mendelbio.com

Published: September 29, 2011

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section


Copyright @ 1992-2024 SeedQuest - All rights reserved